Press release
AI in Biopharmaceutical Development Market to Surge to $13.5 Billion by 2034 at 30% CAGR
AI in Biopharmaceutical Development Market
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1227
According to the latest research by InsightAce Analytic, the global AI in the Biopharmaceutical Development market is valued at USD 991.0 Million in 2024, and it is expected to reach USD 13,518.8 Million by the year 2034, with a CAGR of 30.0% during a forecast period of 2025-2034.
Artificial intelligence (AI) is widely recognized as a transformative technology with significant potential to reshape the biopharmaceutical industry. Encompassing fields such as reasoning, knowledge representation, search algorithms, and machine learning, AI plays a crucial role in enhancing clinical decision-making, optimizing treatment protocols, personalizing therapies, and managing clinical data to support future drug development efforts. In drug discovery, AI enables efficient differentiation between hit and lead compounds, accelerates target validation processes, and aids in the structural optimization of candidate therapeutics.
The increasing adoption of AI within the biopharmaceutical sector is a major factor driving market growth. Rising drug development costs, coupled with growing acknowledgment of AI's capabilities, are expected to further accelerate this expansion. Additional growth drivers include the availability of AI-based drug discovery platforms, heightened demand for these technologies among leading pharmaceutical and biotechnology companies, and active participation from research institutions. The deployment of AI solutions contributes to shortening clinical trial durations, minimizing operational inefficiencies, and improving overall accuracy and productivity.
Nonetheless, the industry encounters several challenges that may restrict market progression. The substantial investment required for AI hardware, software, and applications poses a significant barrier to widespread adoption. Furthermore, limited access to high-quality datasets for drug discovery, a shortage of skilled professionals, and the lack of comprehensive regulatory frameworks and ethical guidelines governing AI usage in healthcare present ongoing obstacles. Effectively addressing these challenges will be essential for sustaining the growth and innovation of AI-driven biopharmaceutical advancements.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
North America is expected to remain a dominant contributor to the AI in Biopharmaceutical Development market throughout the forecast period, driven primarily by the concentration of numerous software and technology providers in the region. Market growth is further supported by the rising prevalence of chronic diseases and significant investments in research and development, particularly within the United States. As a global center for life sciences innovation, the U.S. attracts substantial capital inflows from biopharmaceutical companies worldwide, reinforcing its leading position in the market.
Simultaneously, the Asia Pacific region is projected to experience robust growth in the AI in Biopharmaceutical Development market in the coming years. This expansion is largely attributable to the strategic entry of international players into key markets such as China and India. Moreover, the region's cost-effective manufacturing capabilities and favorable operational conditions are enhancing its appeal as a preferred location for biomanufacturing activities and the advancement of novel therapeutic developments.
Major market players operating in AI in the biopharmaceutical Development market include IBM Watson Health, Google (Alphabet Inc.), Concreto HealthAI, Nvidia Corporation, PathAI, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Ai-biopharma S.A.S., and Microsoft Corporation, among others, are some key players operating in the AI in Biopharmaceutical Development Market.
Recent collaborations and agreements in the market:
• In April 2021, Microsoft acquired Nuance for $19.7 billion, emphasizing healthcare AI. Microsoft will pay Nuance $19.7 billion in cash. With Nuance's conversational AI and speech recognition technologies under its wing, Microsoft will step up its effort to provide cloud-based AI solutions to the healthcare sector on a larger scale.
• In April 2021, On AI-driven drug discovery, Nvidia worked with AstraZeneca and the University of Florida. Through this partnership, researchers will be able to more quickly assess billions of compounds for possible therapeutic candidates thanks to a model trained using the AI supercomputer Nvidia DGX SuperPOD.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1227
Market Segments
Global AI in Biopharmaceutical Development Market, by Type, 2022-2030 (Value US$ Mn)
• Monoclonal antibodies
• Vaccines
• Recombinant proteins
Global AI in Biopharmaceutical Development Market, by Application, 2022-2030 (Value US$ Mn)
• Research and discovery
• Clinical development
• Manufacturing & supply chain and other subsegments
Global AI in Biopharmaceutical Development Market, by End-User, 2022-2030 (Value US$ Mn)
• Biopharmaceutical manufacturers
• Contract manufacturing organizations (CMOs) or contract research organizations (CROs)
• Academic & government research institutes
Global AI in Biopharmaceutical Development Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America AI in Biopharmaceutical Development Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe AI in Biopharmaceutical Development Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific AI in Biopharmaceutical Development Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America AI in Biopharmaceutical Development Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa AI in Biopharmaceutical Development Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global AI in Biopharmaceutical Development market
To receive an industry overview and future trends of the AI in Biopharmaceutical Development market
To analyze the AI in Biopharmaceutical Development market drivers and challenges
To get information on the AI in Biopharmaceutical Development market value (US$Mn) forecast to 2030
Significant investments, mergers & acquisitions in the AI in Biopharmaceutical Development market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-ai-in-biopharmaceutical-development-market-/1227
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Biopharmaceutical Development Market to Surge to $13.5 Billion by 2034 at 30% CAGR here
News-ID: 4111426 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for Biopharmaceutical
Biopharmaceutical third-party logistics Market
Biopharmaceutical Third-Party Logistics Market to reach over USD 176.28 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), Region, Market Outlook And Industry Analysis 2031"
The global Biopharmaceutical third-party logistics market…
Biopharmaceutical Fermentation Market Fueling Biopharmaceutical Innovation: The …
Biopharmaceutical Fermentation Market Worth USD 14.91billion by the year 2030- Exclusive Report by InsightAce Analytic
The newly published report titled "Global Biopharmaceutical Fermentation Market (By Product (Upstream And Downstream Processes), Application (Antibiotics, Recombinant Proteins, Monoclonal Antibodies, Probiotics, And Others), End-User (Biopharmaceutical Industries, Contract Research
Organizations, Food Industries, Academic Research Institutes, And Others))- Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) And Forecast Till 2030." of InsightAce Analytic Pvt. Ltd.…
Biopharmaceutical Cold Chain Transport Market Temperature-controlled Transport f …
Biopharmaceutical Cold Chain Transport Market 2023 Forecast: Unveiling Opportunities and Growth
Biopharmaceutical Cold Chain Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Cold Chain Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of…
Biopharmaceutical Transport Market Transport Se rvices for Biopharmaceutical Pro …
Biopharmaceutical Transport Market 2023 Forecast: Unveiling Opportunities and Growth
Biopharmaceutical Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including the volume of…
Biopharmaceutical Market Industry Analysis - Biopharmaceutical Market Size Drive …
Acumen Research and Consulting has recently published a research report on the Biopharmaceutical Market for the forecast period of 2022 - 2030, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Biopharmaceutical Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2030.
The research study on the Biopharmaceutical Market analyzes key drivers upholding product sales…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
